Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA10 | Q9GZZ6 | 3/20 | 0.64 |
| ▸ | CHRNA9 | Q9UGM1 | 3/20 | 0.64 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.64 |
| ▸ | KLK5 | Q9Y337 | 8/20 | 0.58 |
| ▸ | ACE | P12821 | 1/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.55 |
| ▸ | F12 | P00748 | 4/20 | 0.55 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22195325 | 1.00 | CHRNA10 (0.64) | CHRNA10CHRNA9CHRNA7KLK5ACE | |
| SCHEMBL22195319 | 1.00 | CHRNA10 (0.64) | CHRNA10CHRNA9CHRNA7KLK5ACE | |
| SCHEMBL22195358 | 0.99 | CHRNA10 (0.64) | CHRNA10CHRNA9CHRNA7KLK5ACE | |
| SCHEMBL22195340 | 0.99 | CHRNA10 (0.64) | CHRNA10CHRNA9CHRNA7KLK5ACE | |
| SCHEMBL22195300 | 0.98 | CHRNA10 (0.64) | CHRNA10CHRNA9CHRNA7KLK5ACE | |
| SCHEMBL22195295 | 0.97 | CHRNA10 (0.65) | CHRNA10CHRNA9CHRNA7KLK5ACE | |
| SCHEMBL22195331 | 0.96 | CHRNA10 (0.59) | CHRNA10CHRNA9CHRNA7KLK5ACE | |
| SCHEMBL22195320 | 0.96 | CHRNA10 (0.64) | CHRNA10CHRNA9CHRNA7KLK5ACE | |
| SCHEMBL22195342 | 0.96 | CHRNA10 (0.64) | CHRNA10CHRNA9CHRNA7KLK5ACE | |
| SCHEMBL22195324 | 0.96 | CHRNA10 (0.64) | CHRNA10CHRNA9CHRNA7KLK5ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200237924-A1 | CONOTOXIN PEPTIDE ANALOGS AND USES FOR THE TREATMENT OF PAIN AND INFLAMMATORY CONDITIONS | KINETA CHRONIC PAIN, LLC (US) | 2020-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200237924-A1 | CONOTOXIN PEPTIDE ANALOGS AND USES FOR THE TREATMENT OF PAIN AND INFLAMMATORY CONDITIONS | CHRNG, CHRNA9, CHRNA10 | CHRNA10 3/4885CHRNA9 2/4885CHRNA7 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.